Tumour growth rate (TGR) to monitor growth/predict response to lanreotide autogel (LAN) use before, during and after peptide receptor radionuclide therapy (PRRT) in advanced gastroenteropancreatic neuroendocrine tumours (GEP-NETs): Data from PRELUDE Meeting Abstract


Authors: Prasad, V.; Srirajaskanthan, R.; Grana, C. M.; Baldari, S.; Shah, T.; Lamarca, A.; Courbon, F.; Scheidhauer, K.; Baudin, E.; Truong Thanh, X. M.; Houchard, A.; Bodei, L.
Abstract Title: Tumour growth rate (TGR) to monitor growth/predict response to lanreotide autogel (LAN) use before, during and after peptide receptor radionuclide therapy (PRRT) in advanced gastroenteropancreatic neuroendocrine tumours (GEP-NETs): Data from PRELUDE
Meeting Title: 16th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease
Keywords: peptide; objective response; neuroendocrine tumours; receptor radionuclide therapy; lanreotide autogel; tumour growth rate
Journal Title: Neuroendocrinology
Volume: 108
Issue: Suppl. 1
Meeting Dates: 2019 Mar 6-8
Meeting Location: Barcelona, Spain
ISSN: 0028-3835
Publisher: S. Karger AG  
Date Published: 2019-03-01
Start Page: 158
Language: English
ACCESSION: WOS:000460981800159
PROVIDER: wos
DOI: 10.1159/000498996
Notes: Meeting Abstract: H18 -- Page numbers are not listed on the original publication -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Lisa   Bodei
    205 Bodei